Designed hapten aimed at anti-ciguatoxin monoclonal antibody: Synthesis, immunization and discrimination of the C2 configuration

Synthesis

Volumn , Issue SPEC. ISS., 1999, Pages 1431-1436

  Oguri, Hiroki ^a   Tanaka, Shin Ichiro ^a   Hishiyama, Shojiro ^a   Oishi, Tohru ^a   Hirama, Masahiro ^a   Tumuraya, Takeshi ^b   Tomioka, Yoshihisa ^c   Mizugaki, Michinao ^c  

^a TOHOKU UNIVERSITY   (Japan)

^b Kao Inst for the Fundamental Res   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti ciguatoxin antibody; Artificial antigen; Ciguatoxin; Immunization; Synthetic hapten

Indexed keywords

CIGUATOXIN; HAPTEN; MONOCLONAL ANTIBODY;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CROSS REACTION; CYCLIZATION; DRUG MIXTURE; HAPTEN CARRIER COMPLEX; IMMUNIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EID: 0032807056     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-3646     Document Type: Article

References (24)

1. Present address: Biomolecular Engineering Research Institute, Suita 565.
2. For recent reviews, see: (a) Yasumoto T.; Murata, M. Chem, Rev. 1993, 93, 1897.
3. (b) Scheuer, P. J. Tetrahedron 1994, 50, 3.
4. Relative structure: (a) Murata, M.; Legrand, A. M.; Ishibashi, Y.; Yasumoto, T. J. Am. Chem. Soc. 1989, 111, 8929.
5. (b) Murata, M.; Legrand, A. M.; Ishibashi, Y.; Fukui, M.; Yasumoto, T. ibid. 1990, 112, 4380.
6. Absolute configuration: (a) Satake, M.; Morohashi, A.; Oguri, H.; Oishi, T.; Hirama, M.; Harada, N.; Yasumoto, T. J. Am. Chem. Soc. 1997, 119, 11325.
7. (b) Oguri, H.; Hishiyama, S.; Sato, O.; Oishi, T.; Hirama, M.; Murata, M.; Yasumoto, T.; Harada, N. Tetrahedron 1997, 53, 3057.
8. Yasumoto, T.; Fukui, M.; Sasaki, K.; Sugiyama, K. J. A. O. A. C. Intern. 1995, 78, 574.
9. (a) Hokama Y. Toxicon 1985, 23, 939.
10. (b) Hokama Y.; Hong T.W.P.; Isobe M.; Ichikawa Y.; Yasumoto T. J. Clin. Lab. Analy. 1992, 6, 54.
11. Production of mAbs to the synthetic JKLM-ring fragment-carrier protein conjugates has been reported by K. Tachibana and co-workers, see: Pauillac, S.; Inoue, M.; Sasaki, M.; Naar, J.; Murata, M.; Tachibana, K.; Chinain, M.; Legrand, A. M. Eur. J. Ichthyol., in press.
12. Oguri, H.; Hishiyama, S.; Oishi, T.; Hirama, M. Synlett 1996, 1252, and Ref. 4b.
13. For other synthetic studies of the ABC-ring fragment, see: (a) Hosokawa, S.; Isobe, M. J. Org. Chem. 1999, 64, 37.
14. (b) Oka, T.; Fujiwara, K.; Murai, A. Tetrahedron 1998, 38, 21.
15. Fortunato J. M.; Ganem, B. J. Org. Chem. 1976, 41, 2194.
16. (a) Horita, K.; Hachiya, S.; Nagasawa, M.; Hikota, M.; Yonemitsu, O. Synlett 1994, 38.
17. (b) Burke, S. D.; Jung, K. W.; Phillips, J. R.; Perri, R.E. Tetrahedron Lett. 1994, 35, 703.
18. (c) Kadota, I.; Park, C.-H.; Ohtaka, M.; Oguro, N.; Yamamoto, Y, Tetrahedron Lett. 1998, 39, 6365.
19. The carbon numbering corresponding to that of CTX1B has been used throughout this paper.
20. Kitagawa, T.; Miura, T.; Tanimiya, H. Chem. Pharm. Bull. 1972, 20, 2176.
21. Shinoda T.; Tsuzukida, Y. J. Biochem. 1974, 75, 23.
22. IgG subclass of 4H2, 6F12 and 6H7 was determined as IgG1λ, IgG3κ and IgG1κ, respectively.
23. The 2,11-bis-p-bromobenzoates, 27 and 28, were converted to the 1,2,11-tris-p-bromobenzoates, 29 and 30, which showed the characteristic CD spectra as reported previously. Assignment of the C2 configuration by CD spectra of the tris-p-bromobenzoates is described in Ref 8.
24. ext = 253 nm (Δε+19.4), 236 nm (-4.6).